Histamine H1 receptors in patients with Alzheimer’s disease assessed by positron emission tomography

[1]  M. Higuchi,et al.  Functional neuroimaging of cognition impaired by a classical antihistamine, d‐chlorpheniramine , 2000, British journal of pharmacology.

[2]  H. Arai,et al.  Apolipoprotein E and Alzheimer’s Disease , 1999 .

[3]  P. Blandina,et al.  Cognitive implications for H3 and 5-HT3 receptor modulation of cortical cholinergic function: a parallel story. , 1998, Methods and findings in experimental and clinical pharmacology.

[4]  T. Watanabe,et al.  Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors , 1998, Neuroscience.

[5]  T. Watanabe,et al.  Depletion of brain histamine induced by alpha-fluoromethylhistidine enhances radial maze performance in rats with modulation of brain amino acid levels. , 1998, Life sciences.

[6]  J. Rinne,et al.  Neuronal histamine deficit in Alzheimer's disease , 1997, Neuroscience.

[7]  H Orihara,et al.  Performance evaluation of a large axial field-of-view PET scanner: SET-2400W , 1997, Annals of nuclear medicine.

[8]  Hitoshi Shinotoh,et al.  Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease , 1997, The Lancet.

[9]  N. Volkow,et al.  Imaging the living human brain: magnetic resonance imaging and positron emission tomography. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Cairns,et al.  Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease , 1997, Neuroscience Letters.

[11]  J. Huston,et al.  The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role , 1997, Behavioural Brain Research.

[12]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[13]  I. Taniuchi,et al.  Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Schwartz,et al.  Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity. , 1996, European journal of pharmacology.

[15]  J S Fowler,et al.  PET evaluation of the dopamine system of the human brain. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  M. Jouvet,et al.  Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  J. Hatazawa,et al.  Analysis of plasma metabolites during human PET-studies with three receptor ligands, [11C]YM-09151-2, [11C]doxepin and [11C]pyrilamine. , 1996, The Tohoku journal of experimental medicine.

[18]  M. Mühlethaler,et al.  Cholinergic nucleus basalis neurons are excited by histamine in vitro , 1995, Neuroscience.

[19]  K. Meguro,et al.  Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice , 1995, Pharmacology Biochemistry and Behavior.

[20]  A. Yamatodani,et al.  Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders , 1994, Progress in Neurobiology.

[21]  A. Nordberg.  Clinical studies in Alzheimer patients with positron emission tomography , 1993, Behavioural Brain Research.

[22]  H. Haas,et al.  Histamine potentiates N-methyl-d-aspartate responses in acutely isolated hippocampal neurons , 1993, Neuron.

[23]  J. Kimura,et al.  Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease , 1993, Neuroscience Letters.

[24]  C. Kamei,et al.  Effect of histamine on memory retrieval in old rats. , 1993, Biological & pharmaceutical bulletin.

[25]  Gavin Kilpatrick,et al.  Histamine H3 receptors modulate the release of [3H]‐acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes , 1992, British journal of pharmacology.

[26]  K. Meguro,et al.  Age-dependent decrease in histamine H1 receptor in human brains revealed by PET. , 1992, Neuroreport.

[27]  Jun Hatazawa,et al.  Histamine H1 receptors in human brain visualized in vivo by [11C]doxepin and positron emission tomography , 1992, Neuroscience Letters.

[28]  A. Paetau,et al.  Histamine neurons in human hypothalamus: Anatomy in normal and alzheimer diseased brains , 1991, Neuroscience.

[29]  A. Nicholson,et al.  Sedation and histamine H1‐receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene , 1991, British journal of pharmacology.

[30]  David J. Schlyer,et al.  Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[32]  L. Farde,et al.  Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  R. Cacabelos,et al.  Brain histamine in Alzheimer's disease. , 1989, Methods and findings in experimental and clinical pharmacology.

[34]  T. Spinks,et al.  Performance characteristics of a whole-body positron tomograph. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  J. Green,et al.  Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans. , 1988, Comprehensive gerontology. Section A, Clinical and laboratory sciences.

[36]  M. Jouvet,et al.  Evidence for histaminergic arousal mechanisms in the hypothalamus of cat , 1988, Neuropharmacology.

[37]  D. Collerton,et al.  Cholinergic function and intellectual decline in Alzheimer's disease , 1986, Neuroscience.

[38]  M. Albert,et al.  Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography. , 1985, JAMA.

[39]  J. Haxby,et al.  Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease , 1985, Annals of neurology.

[40]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[41]  P. Panula,et al.  Histamine-containing neurons in the rat hypothalamus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Tanaka,et al.  Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decar☐ylase as a marker , 1984, Brain Research.

[43]  J. Schwartz,et al.  Specific desensitization of histamine H1 receptor-mediated [3H]glycogen hydrolysis in brain slices. , 1981, Molecular pharmacology.

[44]  H. Arai,et al.  CHAPTER 31 – Brain Mapping of the Effects of Aging on Histamine H1 Receptors in Humans: A PET Study with [11C]Doxepin , 1998 .

[45]  T. Nolen.  Sedative effects of antihistamines: safety, performance, learning, and quality of life. , 1997, Clinical therapeutics.

[46]  R. J. Oken.  Antihistamines, a possible risk factor for Alzheimer's disease. , 1995, Medical hypotheses.

[47]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[48]  J. Schwartz,et al.  Histaminergic transmission in the mammalian brain. , 1991, Physiological reviews.

[49]  I. Mazurkiewicz-Kwilecki,et al.  Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients. , 1989, Canadian journal of physiology and pharmacology.

[50]  I. Izquierdo,et al.  Intracerebroventricular histamine, but not 48/80, causes posttraining memory facilitation in the rat. , 1988, Archives internationales de pharmacodynamie et de therapie.

[51]  E. Perry.  The cholinergic hypothesis--ten years on. , 1986, British medical bulletin.

[52]  J. Frost.  Imaging neuronal biochemistry by emission computed tomography: focus on neuroreceptors , 1986 .